Skip to main navigation

Top Navigation

Home
About Us
Technology
Pipeline
Partnerships
Investors
Careers
Contact
- Overview
- Patient Enquiries

Select Page

Event Details

Toolkit

Subscribe
RSS Feeds
Contact IR
Presentations

Event Details

EASL Congress 2023

Jun 21 - Jun 24, 2023

Supporting Materials

HBV002 Final Data Poster - EASL, June 2023 1.9 MB

Barinthus Biotherapeutics plc

Unit 6-10
Zeus Building
Rutherford Avenue
Harwell OX11 0DF
United Kingdom

T: +44 (0)1865 818808

Footer Links

Home
About
Sitemap
Privacy Policy
Privacy Notice
Careers
Contact

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer.

© Barinthus Biotherapeutics 2024 All rights reserved.

Social Media Links

Follow us on X
Follow us on LinkedIn